A patient-driven community dedicated to improving the outcomes for those with EGFR positive lung cancer.

What Is EGFR Lung Cancer?

An EGFR mutation refers to a change (damage) to the portion of the DNA in a cell which carries the β€œrecipe” for making EGFR (epidermal growth factor receptor) proteins. A mutation, or change in the EGFR gene causes the production of higher than normal amounts of EGFR proteins, leading to the growth and spread of cancer cells.

EGFR positive lung cancer refers to lung cancers that test positive for an EGFR mutation and are more common in women than in men.

There are currently five FDA-approved targeted therapies in the United States available to treat first line EGFR positive lung adenocarcinoma. Tagrisso is currently the standard-of-care. Post-Tagrisso treatments can vary depending on what liquid/tissue biopsies show.

Learn More

Find Hope in our Patient and Caregiver Support Group

EGFR Resisters is a family of patients, survivors and caregivers, just like you, who are facing EGFR-positive lung cancer with hope, strength, and compassion.

Why join? Communicate with our active community of over 3100 resisters by posting questions, answers, research, and other helpful information. Learn how others are coping and managing their disease.

Learn More

Our Instagram Wall of Hope